Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

This study has been terminated.
(Unable to accrue patients to the study.)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Northwestern University Identifier:
First received: September 11, 2000
Last updated: June 7, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2001
  Primary Completion Date: September 2001 (Final data collection date for primary outcome measure)